Muscarinic M1 receptor antagonist PIPE-359 shows promising in vivo results for the treatment of MS Oct. 24, 2019
Bicycle Therapeutics, Oxford Drug Discovery Institute to work on therapeutics for dementia Oct. 23, 2019
VBJ-192 and VBJ-215 show encouraging results without tolerance or locomotor side effects Oct. 23, 2019
PD-340 alleviates behavioral deficits related to cognitive impairment in mouse model of AD Oct. 23, 2019
RSS